These findings are congruent with our meta-analysis results taking into consideration that the expression of PD-L1 has been reported to be proportionally low in SCLC in most studies compared to PD-L1 expression in NSCLC [25,74,77,78]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.